Icahn School of Medicine at Mount Sinai
Dr. William Oh, expert in the management of genitourinary malignancies, including prostate, renal, bladder and testicular cancers, is System Chief of the Division of Hematology and Medical Oncology and Deputy Director of the NCI-designated Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. He is Professor of Medicine and Urology and is the Ezra Greenspan, MD Professor of Clinical Cancer Therapeutics.
Dr. Oh’s research interests include novel biomarkers and therapeutics in advanced prostate cancer. In addition to serving as the principal investigator of multiple clinical trials in prostate cancer, he developed large clinical databases and specimen repositories for GU cancers at both Harvard and Mount Sinai which have enrolled over 10,000 patients with prostate, renal and bladder cancer.
Dr. Oh has authored more than 300 original articles, reviews and book chapters on topics relating to prostate, renal, bladder and testicular cancers. He has edited 3 books on prostate cancer. He has served in key invited roles for the American Society of Clinical Oncology (ASCO), the American Cancer Society (ACS) and the American Urological Association (AUA), including the Guidelines Committee for Advanced Prostate Cancer. In addition to reviewing for top journals such as the New England Journal of Medicine, Journal of Clinical Oncology, and Cancer, Dr. Oh co-edits “Testicular Cancer” for Up to Date and is Associate Editor of CA, A Cancer Journal for Clinicians. He was inducted into the prestigious American Society for Clinical Investigation (ASCI) and has been repeatedly selected as a Top Doctor in New York Magazine, Castle Connolly, Best Doctors and Super Doctors over the past decade.
Dr. Oh received his MD from NYU School of Medicine. He completed internship and residency in internal medicine at Brigham and Women’s Hospital in Boston. He completed a fellowship in medical oncology at the DFCI in 1997.
Friday, May 3
10:50 AM – 11:30 AM
Sunday, May 5
3:45 PM – 3:55 PM